Singapore markets open in 8 hours 23 minutes

NGM Biopharmaceuticals Inc (0IK.MU)

Munich - Munich Delayed price. Currency in EUR
Add to watchlist
1.45000.0000 (0.00%)
As of 08:04AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
4,417
4,417
55,333
77,882
87,368
Operating expenses
Research development
118,040
118,040
181,067
161,712
163,972
Selling general and administrative
37,840
37,840
40,515
36,865
27,229
Total operating expenses
155,880
155,880
221,582
198,577
191,201
Operating income or loss
-151,463
-151,463
-166,249
-120,695
-103,833
Total other income/expenses net
-234
-234
-132
-60
-593
Income before tax
-142,375
-142,375
-162,667
-120,335
-102,487
Income from continuing operations
-142,375
-142,375
-162,667
-120,335
-102,487
Net income
-142,375
-142,375
-162,667
-120,335
-102,487
Net income available to common shareholders
-142,375
-142,375
-162,667
-120,335
-102,487
Basic EPS
-1.83
-1.73
-2.03
-1.56
-1.50
Diluted EPS
-1.83
-1.73
-2.03
-1.56
-1.50
Basic average shares
82,247
82,496
79,950
77,085
68,475
Diluted average shares
82,247
82,496
79,950
77,085
68,475